Profile
FLGC ZTS TAK HLN TEVA NBIX
Company Name Flora Growth Corp. Zoetis Inc. Takeda Pharmaceutical Company Limited Haleon plc Teva Pharmaceutical Industries Limited Neurocrine Biosciences, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic Drug Manufacturers - Specialty & Generic
Market Cap $14.70M $67.90B $47.69B $43.90B $21.43B $14.30B
Employees 0.06K 13.80K 49.28K 24.56K 37.00K 1.80K
CEO Clifford A. Starke Kristin C. Peck Christophe Weber Brian James McNamara Richard D. Francis Kyle W. Gano
Ratings
FLGC ZTS TAK HLN TEVA NBIX
Quant Rating Score 1 3 3 3 1 4
Quant Rating Strong Sell Neutral Neutral Neutral Strong Sell Buy
Trading
FLGC ZTS TAK HLN TEVA NBIX
Last Close $27.9 $147.46 $15.12 $9.28 $18.68 $140.9
High 52 $27.9 $196.48 $15.52 $11.41 $22.77 $153.29
Low 52 $0.46 $144.45 $12.89 $9.01 $12.82 $87.59
Price vs. 52 Week High 0 % -24.95 % -2.58 % -18.67 % -17.96 % -8.08 %
Price vs. 52 Week Low 5965.22 % 2.08 % 17.3 % 3 % 45.71 % 60.86 %
Total Return
FLGC ZTS TAK HLN TEVA NBIX
1 Month Return 14.81 % -4.32 % 0.8 % -3.83 % 4.59 % 6.02 %
3 Month Return 3775 % -8.75 % 1.54 % -11.62 % 10.6 % 12.83 %
6 Month Return 4095.49 % -10.7 % -0.4 % -9.99 % 11.79 % 26.31 %
9 Month Return 2305.17 % -13.66 % 13.17 % -6.36 % -10.54 % 3.08 %
YTD Return 2608.74 % -9.49 % 14.2 % -2.73 % -15.25 % 3.22 %
1 Year Return 2305.17 % -24.65 % 1.82 % -12.86 % 4.65 % 15.2 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
FLGC ZTS TAK HLN TEVA NBIX
Dividend Yield Percentage (TTM) - 1.26 % 4.36 % 0.02 % - -
Dividend Paid and Capex Coverage Ration (TTM) -82.35 % 1.89 % 2.03 % - 2.78 % 14.7 %
Dividend Per Share (TTM) - 1.93 % 196 % 0.06 % - -
Payout Ratio (TTM) - 32.08 % 226.17 % - - -
Profitability
FLGC ZTS TAK HLN TEVA NBIX
Gross Profit Margin TTM 21.37 % 70.03 % 60.54 % 61.52 % 49.6 % 98.49 %
Return on Assets TTM -57.67 % 18.04 % 0.98 % 4.2 % -0.39 % 8.95 %
Return on Equity TTM -298.11 % 53.21 % 1.95 % 8.74 % -2.58 % 13.22 %
Return on Capital Employed TTM -148.61 % 31.67 % 3.43 % 7.74 % 3.16 % 14.8 %
Net Income Per EBT TTM 98.1 % 78.72 % 72.1 % 75.5 % 222.54 % 66.08 %
EBT Per Ebit TTM 101.22 % 94.26 % 46.84 % 86.58 % -7.94 % 106.48 %
EBIT Per Revenue TTM -25.14 % 37.51 % 9.05 % 19.64 % 5.38 % 19.72 %
Cash Flow To Debt Ratio TTM -116.32 % 43.13 % 23.79 % - 7.93 % 129.2 %
Receivables Turnover TTM 10.29 6.09 6.59 5.9 4.67 4.21
Payables Turnover TTM 10.82 5.54 4.53 2.19 3.35 0.36
Inventory Turnover TTM 8.58 1.15 1.54 3.63 2.4 0.66
Fixed Asset Turnover TTM 2772.53 % 244.46 % 229.02 % 584.75 % 321.73 % 429.78 %
Asset Turnover TTM 231.05 % 64.82 % 31.99 % 32.73 % 41.43 % 64.53 %
Operating Cash Flow Per Share TTM -1.05 6.58 684.97 - 1.21 5.73
Free Cash Flow Per Share TTM -1.06 4.99 531.34 - 0.78 5.34
Cash Per Share TTM 17.1 % 322.4 % 26788.97 % 24.05 % 188.4 % 985.45 %
Operating Cash Flow Sales Ratio TTM -17.27 % 31.21 % 23.92 % - 8.36 % 22.6 %
Free Cash Flow Operating Cash Flow Ratio TTM 101.21 % 75.76 % 77.57 % - 64.03 % 93.2 %
Cash Flow Coverage Ratios TTM -116.32 % 43.13 % 23.79 % - 7.93 % 129.2 %
Price To Free Cash Flows Ratio TTM -1.61 30.6 8.44 - 24.17 27.05
Price To Operating Cash Flows Ratio TTM -24.17 23.28 6.56 - 15.48 25.16
Price Cash Flow Ratio TTM -24.17 23.28 6.56 - 15.48 25.16
Income Statement (TTM)
FLGC ZTS TAK HLN TEVA NBIX
Revenue $0.06B $9.26B $4581.55B $11.23B $16.54B $2.36B
Gross Profit $0.01B $6.4B $3001.33B $6.95B $8.06B $2.32B
Gross Profit Ratio 21% 69.1% 65.51% 61.85% 48.74% 98.56%
EBITDA $-0.02B $3.87B $1210.51B $2.51B $0.78B $0.64B
Net Income $-0.02B $2.49B $107.93B $1.44B $-1.64B $0.34B
EPS Diluted -1.3 5.47 33.62 0.32 -1.45 3.29
Balance Sheet (MRQ)
FLGC ZTS TAK HLN TEVA NBIX
Long Term Debt $0B $5.39B $4517.23B $8.54B $16.3B $0.46B
Total Liabilities $0.02B $9.47B $7312.37B $18.09B $33.61B $1.13B
Total Equity $0B $4.77B $6935.98B $16.22B $5.72B $2.59B
Total Investments $0B $0B $10.8B $0.08B $0B $1.71B
Total Debt $0B $6.74B $5066.17B $10.1B $18.08B $0.46B
Total Assets $0.03B $14.24B $14248.34B $34.32B $39.33B $3.72B
Cash Flow Statement (TTM)
FLGC ZTS TAK HLN TEVA NBIX
Net Income $-0.02B $2.5B $107.93B $1.44B $-1.96B $0.34B
Inventory $0B $-0.04B $-34.97B $0.22B $0.17B $-0.02B
Dividends Paid $0B $-0.79B $-302.5B $-0.57B $0B $0B
Operating Cash Flow $-0.01B $2.95B $1057.18B $2.3B $1.25B $0.6B
Capital Expenditure $-0B $-0.66B $-200.8B $-0.25B $-0.5B $-0.04B
Related Stocks
Ticker Name Price
ACB Aurora Cannabis Inc. 4.995
ACOR Acorda Therapeutics, Inc. 0.661
ACRX AcelRx Pharmaceuticals, Inc. 0.86
ADMP Adamis Pharmaceuticals Corporation 0.775
ADMS Adamas Pharmaceuticals, Inc. 8.22
AERI Aerie Pharmaceuticals, Inc. 15.25
AGRX Agile Therapeutics, Inc. 1.51
AKAN Akanda Corp. 3.45
ALIM Alimera Sciences, Inc. 5.54
ALVO Alvotech 7.935
ALVOW Alvotech 1.0971
AMPH Amphastar Pharmaceuticals, Inc. 26.99
AMRX Amneal Pharmaceuticals, Inc. 9.61
AMYT Amryt Pharma plc 14.7
ANIP ANI Pharmaceuticals, Inc. 95.33
APUS Apimeds Pharmaceuticals US, Inc 1.79
AQST Aquestive Therapeutics, Inc. 4.825
ASRT Assertio Holdings, Inc. 0.9573
ATNX Athenex, Inc. 0.2031
AVDL Avadel Pharmaceuticals plc 15.67
ETFs With Exposure to FLGC
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.00009 209.23
POTX Global X Cannabis ETF 0.69 5.15
YOLO AdvisorShares Pure Cannabis ETF 0.1 3.12
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.00011 158.72
MJUS ETFMG U.S. Alternative Harvest ETF 3.28 0.7595
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.00011 158.73
VEMPX Vanguard Extended Market Index InstlPlus 0.00011 391.7
Unlock